BioSpace News Archive

Zebra Technologies Corporation, an innovator at the front line of business with solutions and partners that deliver a performance edge, announced the ET4x-HC series, including the Android™-based ET40-HC and ET45-HC tablets, built to improve staff efficiency, care quality and the patient experience.

Nutcracker Therapeutics reveals oncology-focused pipeline programs, with lead candidate in IND-enabling studies.

VBI Vaccines Inc. today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for VBI-1901, a bivalent gB/pp65 immunotherapeutic vaccine candidate for the treatment of glioblastoma (GBM).

Nucleix Expands EU Label Indication of Bladder EpiCheck ® to Include the Detection of Primary Bladder Cancer and Detection of Primary and Recurrent Upper Tract Urinary Cancer.

New biotech company to use crypto to develop treatments for rare diseases.

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), today announced that the first patient has been dosed in the MM cohort of COVALENT-101, the company’s Phase I clinical trial evaluating BMF-219, Biomea’s covalent menin inhibitor, in patients with R/R AML, ALL, DLBCL, and MM.

Global Life Sciences Industry Executive Transitions from Interim CEO Role to Full-Time Leadership Position to Lead Commercialization of Disruptive Diagnostic Technology.

Schrödinger, Inc . (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today will host its second annual Educator’s Day , bringing together K-12 and university educators from across the globe to discuss the growing opportunity for incorporating computational tools in the classroom.

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for Animal Cell Technology (ESCAT), being held from June 26 - 29, 2022 at the Lisbon Congress Centre in Lisbon, Portugal.

Launch of Termeer Scholars Program Will Support Biomedical Researchers and Bring Emerging Talent into the Foundation’s Network of Biotech Innovators.